Treatment of acne vulgaris in pregnant patients

Dermatologic Therapy

Volumn 26, Issue 4, 2013, Pages 302-311

  Pugashetti, Rupa ^a   Shinkai, Kanade ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acne vulgaris; Lactation; Pregnancy; Safety; Treatment

Indexed keywords

ADAPALENE; AMINOLEVULINIC ACID; AMOXICILLIN; ANDROGEN; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; AZELEIC ACID; AZITHROMYCIN; BENZOYL PEROXIDE; CEFALEXIN; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; GLYCOLIC ACID; HYDROQUINONE; KERATOLYTIC AGENT; METRONIDAZOLE; RETINOIC ACID; RETINOID; RETINOL; SALICYLIC ACID; SPIRONOLACTONE; SULFACETAMIDE; SULFONAMIDE; TAZOROTENE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ACNE VULGARIS; ARTICLE; CREAM; DIZZINESS; DRUG CLASSIFICATION; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SOLUTION; FEMINIZATION; FETUS DEVELOPMENT; FETUS OUTCOME; FETUS RISK; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; GEL; HORMONAL ACNE; HUMAN; HYPOSPADIAS; LACTATION; LOTION; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHOTODYNAMIC THERAPY; PREGNANCY OUTCOME; PREGNANT WOMAN; PSEUDOMEMBRANOUS COLITIS; RISK ASSESSMENT; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TOPICAL TREATMENT; YAG LASER;

ACNE VULGARIS; LACTATION; PREGNANCY; SAFETY; TREATMENT;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; LACTATION; LASER THERAPY; PHOTOTHERAPY; PREGNANCY; PREGNANCY COMPLICATIONS; RETINOIDS;

EID: 84885233550     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12077     Document Type: Article

References (45)

1. Lello J, Pearl A, Arroll B, et al. Prevalence of acne vulgaris in Auckland senior high school students. N Z Med J 1995: 1004: 287-289.
2. Collier CN,Harper JC, Cafardi JA, et al. Prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008: 58 (1): 56-59.
3. Yentzer BA, Hick J, Reese EL, et al. Acne vulgaris in the United States: a descriptive epidemiology. Cutis 2010: 86: 94-99.
4. Gupta MA, Gupta AK. The psychological comorbidity in acne. Clin Dermatol 2001: 19: 360-363.
5. Mays RM, Gordon RA, Wilson JM, et al. New antibiotic therapies for acne and rosacea. Dermatol Ther 2012: 25: 23-37.
6. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2012: 379: 361-372.
7. Mancini AJ, Baldwin HE, Eichenfield LF, et al. Acne life cycle: the spectrum of pediatric disease. Semin Cutan Med Surg 2011: 30: S2-S5.
8. Lucky AW, Biro FM, Huster GA, et al. Acne vulgaris in early adolescent boys. Correlations with pubertal maturation and age. Arch Dermatol 1991: 127: 210-216.
9. Loureiro KD, Kao KK, Jones KL, et al. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am JMed Genet 2005: 136 (2): 117-121.
10. Shin J, Cheetham TC, Wong L, et al. The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system. J Am Acad Dermatol 2011: 65: 117-125. doi:10.1016/j.jaad.2010.09.017. Published online May 12, 2011.
11. US. Food and Drug Administration. 2007 Drug Safety and Risk Management Advisory Committee, Dermatologic and Ophthalmic Drugs Advisory Committee. Briefing Document. IPLEDGE year one Update. http://www.fda.gov/ ohrms/dockets/ac/07/briefing/2007-4311b1-02-ipledge. pdf. Accessed December 2010.
12. Nulman I, Berkovitch M, Klein J, et al. Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety. J Clin Pharmacol 1998: 38: 926-930.
13. Lee SM, Kim HM, Lee JS, et al. A case of suspected isotretinoin-induced malformation in a baby of a mother who became pregnant one month after discontinuation of the drug. Yonsei Med J 2009: 50 (3): 445-447.
14. Hersh JH, Danhauer DE, Hand ME, Weisskopf B. Retinoic acid embryopathy: timing of exposure and effects on fetal development. JAMA 1985: 254: 909-910.
15. Dai WS, Hsu MA, Itri LM. Safety of pregnancy after discontinuation of isotretinoin. Arch Dermatol 1989: 125: 362-365.
16. Rafiei R, Yaghoobi R. Azithromycin versus tetracycline in the treatment of acne vulgaris. J Dermatolog Treat 2006: 17 (4): 217-221.
17. Kus S, Yucelten D, Aytug A. Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris. Clin Exp Dermatol 2005: 30 (3): 215-220.
18. Sorensen HT, Skriver MV, Pedersen L, et al. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis 2003: 35: 104-106.
19. Schaefer C, Peters P, Miller RK, et al. Drugs during pregnancy and lactation, 2nd ed. London: Elsevier, 2007.
20. Jick H, Holmes LB, Hunter JR, et al. First-trimester drug use and congenital disorders. JAMA 1981: 246: 343-346.
21. Camera G, Pregliasco P. Ear malformation in baby born to mother using tretinoin cream. Lancet 1992: 339 (8794): 687.
22. Colley SM, Walpole I, Fabian VA, et al. Topical tretinoin and fetal malformations. Med J Aust 1998: 168 (9): 467.
23. Lipson AH, Collins F, Webster WS. Multiple congenital defects associated with maternal use of topical tretinoin. Lancet 1993: 341 (8856): 1352-1353.
24. Navarre-Belhassen C, Blanchet P, Hillaire-Buys D, et al. Multiple congenital malformations associated with topical tretinoin. Ann Pharmacother 1998: 32 (4): 505-506.
25. Selcen D, Seidman S, Nigro MA. Otocerebral anomalies associated with topical tretinoin use. Brain Dev 2000: 22 (4): 218-220.
26. Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet 1993: 341 (8854): 1181-1182.
27. Shapiro L, Pastuszak A, Curto G, et al. Safety of firsttrimester exposure to topical tretinoin: prospective cohort study. Lancet 1997: 350 (9085): 1143-1144.
28. Panchaud A, Csajka C, Merlob P, et al. Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study. J Clin Pharmacol 2012: 42: 1844-1851.
29. Park K, Murase J. Narrowband UVB phototherapy during pregnancy and folic acid depletion. Arch Dermatol 2012: 148: 132-133.
30. Jackson JM, Fu JJ, Almekinder JL. A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/ tretinoin 0.025% gel in the topical treatment of acne vulgaris. J Drugs Dermatol 2010: 9 (2): 131-136.
31. Parry MF, Rha CK. Pseudomembranous colitis caused by topical clindamycin phosphate. Arch Dermatol 1986: 122 (5): 583-584.
32. Del Rosso JQ, Baum EW. Comprehensive medical management of rosacea: an interim study report and literature review. J Clin Aesthet Dermatol 2008: 1 (1): 20-25.
33. Drucker CR. Update on topical antibiotics in dermatology. Dermatol Ther 2012: 25: 6-11.
34. Lookingbill DP, Chalker DK, Lindholm JS, et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 1997: 37 (4): 590-595.
35. Callendar VD. Acne in ethnic skin: special considerations for therapy. Dermatol Ther 2004: 17: 184-195.
36. Murase JE. Fulfilling great expectations: Caring for new mothers and mothers-to-be. Pregnancy: Evidence Based Medicine, presented at 69th Annual Meeting of American Academy of Dermatology, Miami Beach, FL, February 6, 2011.
37. Bozzo P, Chua-Gocheco A, Einarson A, et al. Safety of skin care products during pregnancy. Can Fam Physician 2011: 57: 665-667.
38. Zeichner J. Narrowband UVB phototherapy for the treatment of acne vulgaris during pregnancy. Arch Dermatol 2011: 147: 537-539.
39. Hongcharu W, Taylor CR, Chang Y, et al. Topical ALAphotodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000: 115: 183-192.
40. Lee WJ, Jung HJ, Kim JY, et al. Effect of photodynamic therapy on inflammatory acne using 3% liposomal 5-aminolevulinic acid emulsion and intense-pulsed light: a pilot study. Jpn Dermatol Assoc 2012: 39: 728-729.
41. Lee Y, Baron E. Photodynamic therapy: current evidence and applications in dermatology. Semin Cutan Med Surg 2011: 30: 199-209.
42. Lee WL, Shalita AR, Poh-Fitzpatrick MB. Comparative studies of porphyrin production in Propionibacterium acnes and Propionibacterium granulosum. J Bacteriol 1978: 133: 811-815.
43. Jung JY, Hong JS, Ahn CH, et al. Prospective randomized controlled clinical and histopathological study of acne vulgaris treated with dual mode of quasi-long pulse and Q-switched 1064nm Nd : YAG laser assisted with a topically applied carbon suspension. J Am Acad Dermatol 2012: 66: 626-633.
44. Seaton ED, Charakida A, Mouser PE, et al. Pulsed-dye laser treatment for inflammatory acne vulgaris: randomized controlled trial. Lancet 2003: 362: 1347-1352.
45. El-Saie LT, Rabie AR, Kamel MI, et al. Effect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasis. Lasers Med Sci 2011: 26 (4): 481-485.